Celina M. D’Cruz

Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.

Richard J. Davis, Celina M. D’Cruz, Mark A. Lovell et al. · PubMed · 1994 · 599 citations

Pathology, Cancer Biology, Tumor Biology +16

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

Celina M. D’Cruz, Edward J. Gunther, Robert Boxer et al. · Nature Medicine · 2001 · 417 citations

Spontaneous Kras2 Mutations, Preferred Pathway, Cell Regulation +6

AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and <i>ESR1</i> -Mutant Breast Tumors in Preclinical Models

Hazel M. Weir, Robert H. Bradbury, Mandy Lawson et al. · Cancer Research · 2016 · 174 citations

Persistent Parity-Induced Changes in Growth Factors, TGF-β3, and Differentiation in the Rodent Mammary Gland

Celina M. D’Cruz, Susan E. Moody, Stephen R. Master et al. · Molecular Endocrinology · 2002 · 165 citations · Full text

AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules

Sylvie M. Guichard, Jon Curwen, Teeru Bihani et al. · Molecular Cancer Therapeutics · 2015 · 125 citations · Full text

Breast Oncology, Chemoprevention Strategy, Pharmacotherapy +18